Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Citigroup Downgrades Aerie Pharmaceuticals to Neutral

Citigroup analyst Yigal Nochomovitz downgrades Aerie Pharmaceuticals (NASDAQ:AERI) from Buy to Neutral.

byBenzinga Newsdesk

August 29, 2022

1 minute read

Citigroup analyst Yigal Nochomovitz downgrades Aerie Pharmaceuticals (NASDAQ:AERI) from Buy to Neutral.

BMO Capital Downgrades Take-Two Interactive to Market Perform, Lowers Price Target to $150

By vishwanath@benzinga.com

Today, 7:53 AM

BMO Capital analyst Gerrick Johnson downgrades Take-Two Interactive (NASDAQ:TTWO) from Outperform to Market Perform and lowers the price target from $225 to $150.

TTWO

Aurora Mobile Q2 Revenue Declines 32%, Slashes FY21 Outlook

By Anusuya Lahiri

Today, 7:53 AM

Mobile developer service provider Aurora Mobile Ltd (NASDAQ:JG) reported a second-quarter FY21 revenue decline of 32% year-on-year to $13.8 million (RMB89.0 million),…